381 related articles for article (PubMed ID: 6397768)
1. Factor X.
Jackson CM
Prog Hemost Thromb; 1984; 7():55-109. PubMed ID: 6397768
[No Abstract] [Full Text] [Related]
2. Protein C.
Esmon CT
Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
[TBL] [Abstract][Full Text] [Related]
3. Membrane-bound enzyme complexes in blood coagulation.
Mann KG
Prog Hemost Thromb; 1984; 7():1-23. PubMed ID: 6099581
[No Abstract] [Full Text] [Related]
4. Molecular mechanisms in blood coagulation.
Davie EW; Kirby EP
Curr Top Cell Regul; 1973; 7():51-86. PubMed ID: 4592483
[No Abstract] [Full Text] [Related]
5. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Activation of coagulation in phospholipid phase].
Suzuki K
Rinsho Byori; 1985 Sep; 33(9):966-73. PubMed ID: 3878417
[No Abstract] [Full Text] [Related]
6. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
Krishnaswamy S; Walker RK
Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III.
Baruch D; Lindhout T; Wagenvoord R; Hemker HC
Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193
[TBL] [Abstract][Full Text] [Related]
8. Blood coagulation.
Jackson CM; Nemerson Y
Annu Rev Biochem; 1980; 49():765-811. PubMed ID: 6996572
[No Abstract] [Full Text] [Related]
9. Interactions of vitamin K-dependent proteins with calcium ions and phospholipid membranes.
Nelsestuen GL
Fed Proc; 1978 Oct; 37(12):2621-5. PubMed ID: 700172
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of inhibition of platelet coagulant activity.
Ellis V; Scully MF; Kakkar VV
Adv Exp Med Biol; 1985; 192():373-87. PubMed ID: 2422887
[TBL] [Abstract][Full Text] [Related]
11. The characteristics of anticoagulation by covalently immobilized heparin.
Miura Y; Aoyagi S; Kusada Y; Miyamoto K
J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
[TBL] [Abstract][Full Text] [Related]
13. [Interactions of blood coagulation factors (author's transl)].
Cierniewski CS; Krajewski T
Postepy Biochem; 1981; 27(1):81-105. PubMed ID: 6792614
[No Abstract] [Full Text] [Related]
14. Thrombin generation and inactivation in the presence of antithrombin III and heparin.
Lindhout T; Baruch D; Schoen P; Franssen J; Hemker HC
Biochemistry; 1986 Oct; 25(20):5962-9. PubMed ID: 3790498
[TBL] [Abstract][Full Text] [Related]
15. Role of accessory components in the activation of vitamin K-dependent coagulation factors.
van Rijn JL; Zwaal RF; Hemker HC; Rosing J
Haemostasis; 1986; 16(3-4):216-26. PubMed ID: 3093336
[TBL] [Abstract][Full Text] [Related]
16. Structure and function of protein C.
Stenflo J
Semin Thromb Hemost; 1984 Apr; 10(2):109-21. PubMed ID: 6429858
[No Abstract] [Full Text] [Related]
17. The effect of a sulfated polysaccharide on antithrombin III.
Czapek EE; Kwaan HC; Szczecinski M
J Lab Clin Med; 1980 Jun; 95(6):783-90. PubMed ID: 6155418
[TBL] [Abstract][Full Text] [Related]
18. A new type of antithrombotic agent: action of antithrombin III - factor Xa complex.
Bajwa SS
Proc West Pharmacol Soc; 1981; 24():275-9. PubMed ID: 7255468
[No Abstract] [Full Text] [Related]
19. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
Monteiro RQ; Zingali RB
Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
[TBL] [Abstract][Full Text] [Related]
20. [Prothrombin activation mechanism].
Sakuragawa N
Nihon Rinsho; 1974 May; 32(5):901-9. PubMed ID: 4603779
[No Abstract] [Full Text] [Related]
[Next] [New Search]
